Company: IPSC
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001558370-25-007885
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
Item 1. Unaudited Consolidated Financial Statements.

CENTURY THERAPEUTICS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

​

​​​​​​​​​​​​​    March 31, 2025    December 31, 2024Assets​​​​​​​​​​​​​Current assets​​​​​​Cash and cash equivalents​$ 51,865​$ 58,441Short-term investments​  113,256​  130,851Prepaid expenses and other current assets​  4,510​  4,759Total current assets​  169,631​  194,051​​​​​​​Property and equipment, net​  59,532​  62,141Operating lease right-of-use assets​​ 28,232​​ 28,706Restricted cash​​ 2,775​​ 2,772Long-term investments​  20,713​  30,818Intangible assets​​ 34,200​​ 34,200Security deposits and non-current assets​  526​  528Total assets​$ 315,609​$ 353,216​​​​​​​Liabilities and stockholders’ equity​   ​   ​​​​​​​Current liabilities​   ​   Accounts payable​$ 3,573​$ 3,075Accrued expenses and other liabilities​  10,930​  17,461Deposit liability ​​ -​​ 82Deferred revenue, current​​ -​​ 109,164Total current liabilities​  14,503​  129,782​​​​​​​Operating lease liability, long term​  47,793​  48,960Contingent consideration liability​  8,500​  8,738Deferred tax liability​​ 4,374​​ 4,374​​​​​​​Total liabilities​  75,170​  191,854​​​​​​​Commitments and contingencies (Note 8)​   ​   Stockholders' equity:​​​​​​Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively​​ —​​ —Common stock, $0.0001 par value, 300,000,000  shares authorized; 86,